NOV
37
-2
VRTX
43
6
LNC
48
5
PFG
40
6
EBAY
62
9
ED
45
2
SYF
72
3
JCI
57
7
LUV
56
4
PPL
65
3
LB
28
-7
MET
64
3
PX
40
-5
MSFT
64
-3
KIM
51
-3
BBY
40
4
FOX
51
3
MMC
53
2
DD
38
-2
LRCX
62
-3
NOV
37
-2
VRTX
43
6
LNC
48
5
PFG
40
6
EBAY
62
9
ED
45
2
SYF
72
3
JCI
57
7
LUV
56
4
PPL
65
3
LB
28
-7
MET
64
3
PX
40
-5
MSFT
64
-3
KIM
51
-3
BBY
40
4
FOX
51
3
MMC
53
2
DD
38
-2
LRCX
62
-3
Financhill
Back

iShares JPX-Nikkei 400 ETF Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
52

JPXN
iShares JPX-Nikkei 400 ETF

Last Price:
$76.8100
Seasonality Move:
1.21%
Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
$17.70
Seasonality Move:
-9.52%
Buy
52
iShares JPX-Nikkei 400 ETF (JPXN) is a Buy

Is iShares JPX-Nikkei 400 ETF a Buy, Sell or Hold?

  • The current iShares JPX-Nikkei 400 ETF [JPXN] share price is $76.8292. The Score for JPXN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • JPXN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $17.69. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JPXN Stock Price Chart

What is iShares JPX-Nikkei 400 ETF's stock price today?

  • The iShares JPX-Nikkei 400 ETF share price today is $76.8292
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JPXN is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $17.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

JPXN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.27 Buy
Relative Strength Index (14 RSI): 43.98 Sell
Chaikin Money Flow: -11428 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.43 - 79.15) Sell
Bollinger Bands (100): (71.8052 - 77.7052) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 42.98 Sell
Chaikin Money Flow: -561522 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.2 - 19.06) Sell
Bollinger Bands (100): (17.72 - 26.54) Sell

JPXN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.21 Sell
20-day SMA: 78.54 Sell
50-day SMA: 76.52 Buy
200-day SMA: 74.01 Buy
8-day EMA: 77.98 Sell
20-day EMA: 78.07 Sell
50-day EMA: 76.85 Sell
200-day EMA: 74.2 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.56 Sell
20-day SMA: 18.3 Sell
50-day SMA: 18.27 Sell
200-day SMA: 26.83 Sell
8-day EMA: 18.25 Sell
20-day EMA: 18.36 Sell
50-day EMA: 19.23 Sell
200-day EMA: 26.97 Sell

iShares JPX-Nikkei 400 ETF Earnings Growth & JPXN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.

iShares JPX-Nikkei 400 ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):